Icos
Executive Summary
Announces initial public offering of 4.5 mil. shares. The company, founded in 1989, is on the financing fast-track: based on the biotech pedigree of its founders, Chairman George Rathmann, PhD, (a founder of Amgen) President and CEO Robert Nowinski, PhD, (founder of Genetics Systems) and Science Director Christopher Henney, PhD, (a founder of Immunex), Icos raised $ 33 mil. in a June 1990 private placement. PaineWebber, who handled that deal for the Blech brothers, will comanage the offering with Lehman Brothers. Seattle-based Icos is developing treatments for chronic inflammatory diseases.